The new executive order promises support for R&D and commercialization as well as to grow production capacity for greener chemicals and fuels. It also establishes a new data-sharing program and directs federal agencies to buy more bio-based products. (The Logic)

Talking point: The order signed Monday doesn’t include financial figures, but the White House is promising funding announcements at a summit Wednesday. The Biden administration has taken a cash- and policy-heavy approach to tech subsectors where it sees opportunities for growth, or risks—particularly from competition from China—to be mitigated. Other areas of focus include chips and quantum. Canada has launched its own bio-strategies in recent years. The April 2021 federal budget allocated $2.2 billion for life-sciences programs, plus $1 billion from Ottawa’s flagship innovation fund for biomanufacturing; it’s already backed pharmaceutical firms like Sanofi and Moderna. The federal Clean Fuels Fund will allocate another $1.5 billion for projects that will produce biocrude, cellulosic ethanol, hydrogen and other low-carbon products, although firms say the program has delayed decisions on applications.